Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Siro Clinpharm Private Limited, is an unlisted private company incorporated on 21 March, 2000. It is classified as a private limited company and is located in Mumbai, Maharashtra. It's authorized share capital is INR 25.00 cr and the total paid-up capital is INR 6.10 lac.
Siro Clinpharm's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2022. It's EBITDA has increased by 79.6% over the previous year. At the same time, it's book networth has increased by 76.45%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2022 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|---|---|
Maharashtra | Registered Office | 16th Floor, Hoechst House, Nariman Point, Mumbai Mumbai Cit y MH 400021 Nariman Point Mumbai Mumbai Maharashtra - 400021 |
Maharashtra | Warehouse | IST FLOOR, UNIT NO 3 and 4, KALPATARU PRIME, ROAD NO 16, WAGLE INDUSTRIAL ESTATE THANE W, Thane, Maharashtra, 400604 |
Maharashtra | Warehouse | PLOT NO. 83 B 2, Nr Kala Industrial Estate, Opp Shangarila Biscuits Factory Bhandup W, Mumbai Suburban, Maharashtra, 400078 |
Maharashtra | Warehouse | Plot No B 41, Asmaco House, Road No 27, Wagle Estate Thane W, Thane, Maharashtra, 400604 |
Maharashtra | Warehouse | 16th floor, Plot No. 193, Block 3 Backbay Reclamation, HOECHST House of Venkatesh Premises Co- Operative Society, Nariman point, Nariman Point, Mumbai, Mumbai, Maharashtra, 400021 |
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Gautam Vinod Daftary
Shareholder
|
00009326 | 25 years |
Director | Akshay Gautam Daftary | 07557623 | 7 years |
Whole-time Director | Karan Gautam Daftary | 08221120 | 7 years |
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Daimler Financial Services India Private Limited
No. of Loans: 1
Total Amount : 1.0 cr
Total Amount : 1.0 cr
Charge Date : 24 Nov, 2021
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
SIRO CLINPHARM USA LLC | - | - | - |
Read more
The incorporation date of SIRO CLINPHARM PRIVATE LIMITED is 21 March, 2000
The authorized share capital of SIRO CLINPHARM PRIVATE LIMITED is INR ₹ 25.0 Cr.
The paid-up capital of SIRO CLINPHARM PRIVATE LIMITED is INR ₹ 6.1 L.
The registered address of SIRO CLINPHARM PRIVATE LIMITED is 16th Floor, Hoechst House, Nariman Point, Mumbai Mumbai Cit y MH 400021 Nariman Point Mumbai Mumbai Maharashtra - 400021
The CIN number of SIRO CLINPHARM PRIVATE LIMITED is U24230MH2000PTC125061.